P

ProQR Therapeutics NV
D

PRQR

3.62000
USD
0.01
(0.14%)
Market Closed
Volume
23,000
EPS
-0
Div Yield
-
P/E
-12
Market Cap
383,383,050
OverviewSignalsIdeasNews
Related Instruments
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    C
    CYTK
    -4.440
    (-8.12%)
    50.270 USD
    G
    GLPG
    -1.130
    (-4.05%)
    26.780 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    104.29 USD
    S
    SAGE
    -0.26000
    (-4.84%)
    5.11000 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    More
News

Title: ProQR Therapeutics NV

Sector: Healthcare
Industry: Biotechnology
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.